134 related articles for article (PubMed ID: 38064145)
1. Enhancing transmucosal delivery of CBD through nanoemulsion: in vitro and in vivo studies.
Provenzano R; De Caro C; Vitiello A; Izzo L; Ritieni A; Ungaro F; Quaglia F; Russo E; Miro A; d'Angelo I
Drug Deliv Transl Res; 2024 Jun; 14(6):1648-1659. PubMed ID: 38064145
[TBL] [Abstract][Full Text] [Related]
2. Formulation and In Vitro-Ex vivo Evaluation of Cannabidiol and Cannabidiol-Valine-Hemisuccinate Loaded Lipid-Based Nanoformulations for Ocular Applications.
Adel Ali Youssef A; Hayder Abdelrahman M; Geweda MM; Varner C; Joshi PH; Ghonge M; Dudhipala N; Sulochana SP; Gadepalli RS; Majumdar S
Int J Pharm; 2024 May; 657():124110. PubMed ID: 38604539
[TBL] [Abstract][Full Text] [Related]
3. Development of cannabidiol nanoemulsion for direct nose to brain delivery: statistical optimization,
Ahmed B; Rizwanullah M; Mir SR; Akhtar MS; Amin S
Biomed Mater; 2022 Sep; 17(6):. PubMed ID: 36108625
[TBL] [Abstract][Full Text] [Related]
4. The effect of Pro NanoLipospheres (PNL) formulation containing natural absorption enhancers on the oral bioavailability of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) in a rat model.
Cherniakov I; Izgelov D; Domb AJ; Hoffman A
Eur J Pharm Sci; 2017 Nov; 109():21-30. PubMed ID: 28736128
[TBL] [Abstract][Full Text] [Related]
5. Development and pharmacokinetic evaluation of a self-nanoemulsifying drug delivery system for the oral delivery of cannabidiol.
Kok LY; Bannigan P; Sanaee F; Evans JC; Dunne M; Regenold M; Ahmed L; Dubins D; Allen C
Eur J Pharm Sci; 2022 Jan; 168():106058. PubMed ID: 34763088
[TBL] [Abstract][Full Text] [Related]
6. Nanosuspension-Loaded Dissolving Microneedle Patches for Enhanced Transdermal Delivery of a Highly Lipophilic Cannabidiol.
Cheng A; Zhang S; Meng F; Xing M; Liu H; Yang G; Gao Y
Int J Nanomedicine; 2024; 19():4061-4079. PubMed ID: 38736651
[TBL] [Abstract][Full Text] [Related]
7. Piperine-pro-nanolipospheres as a novel oral delivery system of cannabinoids: Pharmacokinetic evaluation in healthy volunteers in comparison to buccal spray administration.
Cherniakov I; Izgelov D; Barasch D; Davidson E; Domb AJ; Hoffman A
J Control Release; 2017 Nov; 266():1-7. PubMed ID: 28890215
[TBL] [Abstract][Full Text] [Related]
8. Boosting transdermal delivery of atorvastatin calcium via o/w nanoemulsifying system: Two-step optimization, ex vivo and in vivo evaluation.
Shaker DS; Ishak RAH; Elhuoni MA; Ghoneim AM
Int J Pharm; 2020 Mar; 578():119073. PubMed ID: 31982556
[TBL] [Abstract][Full Text] [Related]
9. Solid self-nanoemulsifying drug delivery system (S-SNEDDS) of darunavir for improved dissolution and oral bioavailability: In vitro and in vivo evaluation.
Inugala S; Eedara BB; Sunkavalli S; Dhurke R; Kandadi P; Jukanti R; Bandari S
Eur J Pharm Sci; 2015 Jul; 74():1-10. PubMed ID: 25845633
[TBL] [Abstract][Full Text] [Related]
10. The effect of medium chain and long chain triglycerides incorporated in self-nano emulsifying drug delivery systems on oral absorption of cannabinoids in rats.
Izgelov D; Shmoeli E; Domb AJ; Hoffman A
Int J Pharm; 2020 Apr; 580():119201. PubMed ID: 32147493
[TBL] [Abstract][Full Text] [Related]
11. A pilot safety, tolerability and pharmacokinetic study of an oro-buccal administered cannabidiol-dominant anti-inflammatory formulation in healthy individuals: a randomized placebo-controlled single-blinded study.
Vitetta L; Butcher B; Henson JD; Rutolo D; Hall S
Inflammopharmacology; 2021 Oct; 29(5):1361-1370. PubMed ID: 34357480
[TBL] [Abstract][Full Text] [Related]
12. A Novel Self-Emulsifying Drug Delivery System (SEDDS) Based on VESIsorb
Knaub K; Sartorius T; Dharsono T; Wacker R; Wilhelm M; Schön C
Molecules; 2019 Aug; 24(16):. PubMed ID: 31426272
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a nanoemulsion formulation strategy for oral bioavailability enhancement of danazol in rats and dogs.
Devalapally H; Silchenko S; Zhou F; McDade J; Goloverda G; Owen A; Hidalgo IJ
J Pharm Sci; 2013 Oct; 102(10):3808-15. PubMed ID: 23878097
[TBL] [Abstract][Full Text] [Related]
14. Fabrication, Characterization, In vitro Evaluation of Solid Lipid Nanoemulsion of Flunarizine dihydrochloride for Nasal Delivery.
Newton MJ; Harjot K
Antiinflamm Antiallergy Agents Med Chem; 2017; 15(3):204-220. PubMed ID: 27993106
[TBL] [Abstract][Full Text] [Related]
15. Prolonged oral transmucosal delivery of highly lipophilic drug cannabidiol.
Itin C; Barasch D; Domb AJ; Hoffman A
Int J Pharm; 2020 May; 581():119276. PubMed ID: 32243971
[TBL] [Abstract][Full Text] [Related]
16. Studies on self-nanoemulsifying drug delivery system of flurbiprofen employing long, medium and short chain triglycerides.
Daar J; Khan A; Khan J; Khan A; Khan GM
Pak J Pharm Sci; 2017 Mar; 30(2(Suppl.)):601-606. PubMed ID: 28650328
[TBL] [Abstract][Full Text] [Related]
17. Key Transdermal Patch Using Cannabidiol-Loaded Nanocarriers with Better Pharmacokinetics in vivo.
Chu PC; Liao MH; Liu MG; Li CZ; Lai PS
Int J Nanomedicine; 2024; 19():4321-4337. PubMed ID: 38770103
[TBL] [Abstract][Full Text] [Related]
18. Influence of Polysorbate 60 on Formulation Properties and Bioavailability of Morin-Loaded Nanoemulsions with and without Low-Saponification-Degree Polyvinyl Alcohol.
Ikeuchi-Takahashi Y; Kobayashi A; Ishihara C; Matsubara T; Matsubara H; Onishi H
Biol Pharm Bull; 2018; 41(5):754-760. PubMed ID: 29709912
[TBL] [Abstract][Full Text] [Related]
19. Development of a Novel Nano-emulsion Formulation to Improve Intestinal Absorption of Cannabidiol.
Nakano Y; Tajima M; Sugiyama E; Sato VH; Sato H
Med Cannabis Cannabinoids; 2019 Sep; 2(1):35-42. PubMed ID: 34676332
[TBL] [Abstract][Full Text] [Related]
20. Lipid-based formulations to increase cannabidiol bioavailability: In vitro digestion tests, pre-clinical assessment and clinical trial.
De Prá MAA; Vardanega R; Loss CG
Int J Pharm; 2021 Nov; 609():121159. PubMed ID: 34624443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
